Victoria Adelus Field

Chronic migraines and bad sleep might share similar metabolic roots. Italian researchers followed 26 chronic migraine patients on a ketogenic diet or low glycemic index diet for six months. Both groups restricted carbs to about 30 grams daily. The results: sleep quality improved, daytime sleepiness dropped, and migraine frequency and intensity both came down. The most interesting part? Sleep improvements were independent of migraine improvements. This wasn't simply fewer headaches leading to better rest. The metabolic shift itself appeared to change sleep architecture. And the benefits showed up by only three months. Extending to six months didn't add further improvement, which led the researchers to question whether a three-month intervention might be enough. If you deal with chronic migraine and trouble sleeping, the metabolic connection is worth understanding. Want to learn about more studies like this? Our free ketogenic metabolic therapy ebook covers more than 150 synthesized peer-reviewed papers on findings like this. Get access at the link below.

At the Coalition for Metabolic Health, we're working to address America's chronic disease crisis. Learn more about our mission to make metabolic health mainstream—and hear directly from some of our experts—in our new video:

We just released Volume 4 of our Ketogenic Metabolic Therapy eBook as a completely free public resource. No trial. No membership required. Click the link in the comments below and we’ll send it directly to your inbox. Inside: 150+ peer-reviewed papers across oncology, metabolic psychiatry, metabolic disease, human performance, and more — each distilled into clear, clinician-friendly highlights with direct source links. The response from clinicians, researchers, and educators made one thing clear: this needed to be accessible to everyone. If it helps more people understand the science, ask better questions, and practice more informed medicine, that’s a win. If you read it, we’d genuinely love your feedback. Metabolic therapy will shape the future of medicine. Thank you for helping us share it.

Ketogenic diets in the ICU? The research is beginning to explore it. In a randomized controlled trial of 40 patients with sepsis, investigators tested a medically supervised ketogenic diet during critical illness. All patients in the ketogenic group achieved stable nutritional ketosis, with no serious adverse events attributed to the intervention. After day four, none of the ketogenic patients required insulin — compared to 35–60% of patients in the control group on any given day. The ketogenic group also experienced: • More ventilator-free days • More vasopressor-free days • More dialysis-free days • More ICU-free days Researchers observed signals consistent with reduced immune dysregulation and lower inflammatory signaling — a meaningful finding in a condition defined by metabolic chaos and systemic inflammation. This was a small, early-phase trial. It does not establish standard of care. But it adds to a growing body of evidence that metabolic therapy may have applications beyond chronic disease — including critical care. Check out the link below with details on how to access 150+ research summaries on metabolic health and therapy in our new Ketogenic Metabolic Therapy eBook!

We just released the latest edition of our Ketogenic Metabolic Therapy eBook on the Metabolic Initiative platform! This volume synthesizes more than 150 recent peer-reviewed studies across oncology, metabolic dysfunction, neurology (including metabolic psychiatry), human performance, and related areas of medicine. Each paper is distilled into: • What was studied • What was found • Why it may matter mechanistically or clinically Our intention is to make it easier for you to stay oriented to a rapidly expanding field, without having to spend hours reading dozens of individual publications. The eBook is available with a 7-day trial of The Metabolic Initiative, which also includes hundreds of CME-eligible lectures, expert interviews, additional research eBooks, private ad-free episodes of The Metabolic Link, and Live Q&As with world-renowned researchers and clinicians.  Find the link to access the ebook below.

A new study suggests that ketosis may help overcome immunotherapy resistance in prostate cancer. In this preclinical study, researchers found that beta-hydroxybutyrate (the primary ketone body produced during fasting or a ketogenic diet) increased MHC class I expression on prostate cancer cells — effectively making them more visible to the immune system. It also reshaped the tumor microenvironment: • ↑ CD8+ cytotoxic T cells • ↓ Immunosuppressive cells When a cyclic ketogenic diet or ketone supplementation was combined with immunotherapy in resistant mouse models, tumors that previously failed to respond began shrinking — and ~20% achieved a complete response. When ketone production was blocked, the effect disappeared. When adaptive immunity was removed, the effect disappeared. In other words, the metabolic intervention and the immune system were working together. This is not a cure. It’s a proof of concept. But it suggests something important: metabolic therapy may have the potential to restore immunotherapy sensitivity in cancers that are currently considered immunologically “cold,” like advanced prostate cancer. That’s a meaningful direction for future research. You can find the full paper linked below.

What would you say if every participant in a clinical trial reversed metabolic syndrome… and psychiatric symptoms improved by ~30%? That’s what researchers at Stanford observed when adults with schizophrenia or bipolar disorder were placed on a clinician-supervised ketogenic diet for four months, while remaining on their psychiatric medications. This was a small, early-phase study. But it’s part of a growing area of research known as metabolic psychiatry, one that’s actively being investigated. Importantly, these findings do not mean metabolic interventions replace medication. These trials are focused on identifying approaches that may support or enhance standard care, and much more research is needed to understand their clinical potential. Encouragingly, additional randomized controlled trials are already underway. The original paper is linked in below. We’ll continue sharing research highlights like this as the evidence evolves. Please note this content is for educational purposes and reflects ongoing research. If you or someone you love is struggling with mental illness, always consult with your physician before starting metabolic therapy